ELDERVIT

Main information

  • Trade name:
  • ELDERVIT 100ML SYR
  • Dosage:
  • 1.5MG,1.2MG,15MG,1.5MG,1MG,0.5MG,50MG,200IU.;5ML
  • Pharmaceutical form:
  • SYR
  • Composition:
  • 100ML
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ELDERVIT 100ML SYR
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

29-6-2017

FDA allows marketing of test to aid in the detection of certain leukemias and lymphomas

FDA allows marketing of test to aid in the detection of certain leukemias and lymphomas

The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).

FDA - U.S. Food and Drug Administration